ROK
50
2
AKAM
53
3
CFG
50
8
DVA
68
-4
SE
49
-6
MKC
42
-2
CF
41
-3
CL
70
-4
MMM
30
-3
MCO
77
3
QCOM
78
8
UHS
54
-8
KMB
39
-3
MCHP
54
4
JNPR
63
4
TXT
72
-3
MAR
50
-3
UA
44
-3
CHD
56
-2
VRSK
84
-5
ROK
50
2
AKAM
53
3
CFG
50
8
DVA
68
-4
SE
49
-6
MKC
42
-2
CF
41
-3
CL
70
-4
MMM
30
-3
MCO
77
3
QCOM
78
8
UHS
54
-8
KMB
39
-3
MCHP
54
4
JNPR
63
4
TXT
72
-3
MAR
50
-3
UA
44
-3
CHD
56
-2
VRSK
84
-5
Financhill
Back

Global Payments Vs. Viking Therapeutics Industry Stock Comparison

Sell
34

GPN
Global Payments

Last Price:
96.74
Seasonality Move:
2.35%
Sell
47

VKTX
Viking Therapeutics

Last Price:
52.96
Seasonality Move:
1.76%
Sell
34
Global Payments (GPN) is a Sell

Is Global Payments a Buy, Sell or Hold?

  • The current Global Payments [GPN] share price is $96.70. The Score for GPN is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • GPN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $52.96. The Score for VKTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GPN Stock Price Chart

What is Global Payments's stock price today?

  • The Global Payments share price today is $96.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPN is experiencing buying pressure, which is a positive indicator for future bullish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $52.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.

GPN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.97 Sell
Relative Strength Index (14 RSI): 42.04 Sell
Chaikin Money Flow: 2148336 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (94.34 - 100.3) Sell
Bollinger Bands (100): (103.82 - 133.28) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.9 Sell
Relative Strength Index (14 RSI): 43.41 Sell
Chaikin Money Flow: 113403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.34 - 60.74) Sell
Bollinger Bands (100): (47.23 - 79.29) Sell

GPN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 95.12 Buy
20-day SMA: 96.23 Buy
50-day SMA: 106.1 Sell
200-day SMA: 119.35 Sell
8-day EMA: 95.57 Buy
20-day EMA: 97.33 Sell
50-day EMA: 104.87 Sell
200-day EMA: 115.99 Sell

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.6 Buy
20-day SMA: 53.66 Sell
50-day SMA: 63.66 Sell
200-day SMA: 39.18 Buy
8-day EMA: 51.13 Buy
20-day EMA: 54.21 Sell
50-day EMA: 59.37 Sell
200-day EMA: 45.7 Buy

Global Payments Earnings Growth & GPN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.17 per share, an increase this year of $1.25 per share, and an increase next year of $1.56 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.

Global Payments Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):